Menu

Client Success Stories

30% of the F100 use BTG's platform to access high-end independent talent on projects like...

Assessing an Acquisition’s Market Access Potential

A multi-million-dollar pharmaceutical company was in talks to acquire an orphan drug manufacturer with a pipeline asset that was about to launch in Europe. The company’s corporate development team was focused on the deal’s financials, but they lacked the expertise to assess the access potential of the new drug. Looking for highly targeted due diligence support, they turned to Business Talent Group (BTG).

BTG engaged a former Deloitte consultant who’d held senior market access roles at top global pharma companies. He investigated the target’s launch plans and timing for the new asset, along with early pricing and reimbursement estimates. He also evaluated the deal’s implications to the company’s broader commercial strategy and how post-integration staffing could affect the asset’s launch.

Industries: Pharma/Life Science
Project Types: Growth , M&A
Functions: Corp Dev / BD , Marketing

 

 

© 2018 Business Talent Group, all rights reserved. Business Talent Group and BTG are trademarks of Business Talent Group.